239.77 USD
▼-25.15-9.49%
盘后 240.00 +0.10%
2026-09-15
市值
$15.75B
市盈率
17.91
EPS
13.38
股息率
—
52 周区间
203.80 – 282.15
成交量
2.96M
Beta
0.48
目标价
312.54
52W 低 203.8052W 高 282.15
价格走势
公司简介
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing o...